Title |
Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study
|
---|---|
Published in |
PLOS ONE, May 2013
|
DOI | 10.1371/journal.pone.0064217 |
Pubmed ID | |
Authors |
Irina Vasilyeva, Robert G. Biscontri, Murray W. Enns, Colleen J. Metge, Silvia Alessi-Severini |
Abstract |
Despite concerns over the potential for severe adverse events, antipsychotic medications remain the mainstay of treatment of behaviour disorders and psychosis in elderly patients. Second-generation antipsychotic agents (SGAs; e.g., risperidone, olanzapine, quetiapine) have generally shown a better safety profile compared to the first-generation agents (FGAs; e.g., haloperidol and phenothiazines), particularly in terms of a lower potential for involuntary movement disorders. Risperidone, the only SGA with an official indication for the management of inappropriate behaviour in dementia, has emerged as the antipsychotic most commonly prescribed to older patients. Most clinical trials evaluating the risk of movement disorders in elderly patients receiving antipsychotic therapy have been of limited sample size and/or of relatively short duration. A few observational studies have produced inconsistent results. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 25% |
Canada | 1 | 25% |
United States | 1 | 25% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Finland | 1 | 2% |
Unknown | 48 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 14% |
Researcher | 6 | 12% |
Student > Bachelor | 6 | 12% |
Other | 5 | 10% |
Student > Ph. D. Student | 5 | 10% |
Other | 11 | 22% |
Unknown | 9 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 35% |
Psychology | 7 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 10% |
Agricultural and Biological Sciences | 2 | 4% |
Sports and Recreations | 1 | 2% |
Other | 6 | 12% |
Unknown | 11 | 22% |